Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients

Bone Marrow Transplantation volume 36, pages 411–415 (2005)Cite this article

Summary:

Influenza is one of the most common respiratory diseases in humans. The response to vaccination is frequently poor in immunosuppressed individuals. The aim of the present study was to develop an enzyme-linked immunospot (ELISPOT) assay for measuring of the specific T-cell response to influenza vaccination. In all, 18 healthy subjects and six stem cell transplantation (SCT) patients tested before and 4 weeks after influenza vaccination were included in the present study. Peripheral blood lymphocytes were stimulated with four influenza peptides; three based on sequences from the hemagglutinin and one from the M1 protein. The ELISPOT assay and the measurement of intracellular IFN-γ production were used to determine the cell-mediated responses after stimulation with the peptides. Influenza vaccination elicited strong cell-mediated immune responses in the healthy controls to all four peptides with 3.2–6.9-fold increases in the number of IFN-γ producing spots/106 cells. By intracellular staining, it was suggested that CD4+ cells mediated the responses to the hemagglutinin peptides. In contrast, there was no increase in the number of IFN-γ producing cells response after vaccination in the six SCT patients. In conclusion, our results suggest that the ELISPOT assay might be used as a complement to serology for monitoring of future influenza vaccine studies in SCT patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Nicholson KG, Wood JM, Zambon M . Influenza. Lancet 2003; 362: 1733–1745.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ljungman P, Cordonnier C, de Bock R et al. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995; 15: 455–460.

    CAS  PubMed  Google Scholar 

  3. Nicholson KG, Snacken R, Palache AM . Influenza immunization policies in Europe and the United States. Vaccine 1995; 13: 365–369.

    Article  CAS  PubMed  Google Scholar 

  4. Cox NJ, Subbarao K . Influenza. Lancet 1999; 354: 1277–1282.

    Article  CAS  PubMed  Google Scholar 

  5. Pauksen K, Linde A, Hammarstrom V et al. Granulocyte–macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000; 30: 342–348.

    Article  CAS  PubMed  Google Scholar 

  6. Gribabis DA, Panayiotidis P, Boussiotis VA et al. Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 1994; 91: 115–118.

    Article  CAS  PubMed  Google Scholar 

  7. Lo W, Whimbey E, Elting L et al. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis 1993; 12: 778–782.

    Article  CAS  PubMed  Google Scholar 

  8. Engelhard D, Nagler A, Hardan I et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993; 11: 1–5.

    CAS  PubMed  Google Scholar 

  9. Robertson JD, Nagesh K, Jowitt SN et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000; 82: 1261–1265.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rapezzi D, Sticchi L, Racchi O et al. Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol 2003; 70: 225–230.

    Article  PubMed  Google Scholar 

  11. Dercamp C, Sanchez V, Barrier J et al. Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay. Clin Diag Lab Immunol 2002; 9: 230–235.

    CAS  Google Scholar 

  12. Haining W, Evans J, Seth N et al. Measuring T cell immunity to influenza vaccination in children after haematopoietic stem cell transplantation. British J Haematol 2004; 12: 322–325.

    Article  Google Scholar 

  13. Rajnavolgyi E, Nagy Z, Kurucz I et al. T cell recognition of the posttranslationally cleaved intersubunit region of influenza virus hemagglutinin. Mol Immunol 1994; 31: 1403–1414.

    Article  CAS  PubMed  Google Scholar 

  14. Currier JR, Kuta EG, Turk E et al. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods 2002; 260: 157–172.

    Article  CAS  PubMed  Google Scholar 

  15. Rauser G, Einsele H, Sinzger C et al. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 2004; 103: 3565–3572.

    Article  CAS  PubMed  Google Scholar 

  16. Guillaume T, Rubinstein DB, Symann M . Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 92; 1998: 1471–1490.

    Google Scholar 

  17. Ljungman P . Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102: 44–47.

    Article  CAS  PubMed  Google Scholar 

  18. Louria DB, Blumenfeld HL, Ellis JT et al. Studies on influenza in the pandemic of 1957–1958. II. Pulmonary complications of influenza. J Clin Invest 1959; 38: 213–265.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Whimbey E, Elting LS, Couch RB et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437–440.

    CAS  PubMed  Google Scholar 

  20. Ljungman P, Ward KN, Crooks BN et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479–484.

    Article  CAS  PubMed  Google Scholar 

  21. Raboni SM, Nogueira MB, Tsuchiya LR et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003; 76: 142–146.

    Article  PubMed  Google Scholar 

  22. Gianfrani C, Oseroff C, Sidney J et al. Human memory CTL response specific for influenza A virus is broad and multispecific. Hum Immunol 2000; 61: 438–452.

    Article  CAS  PubMed  Google Scholar 

  23. Mackall CL, Fleisher TA, Brown MR et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89: 3700–3707.

    CAS  PubMed  Google Scholar 

  24. Novitzky N, Davison GM . Immune reconstitution following hematopoietic stem-cell transplantation. Cytotherapy 2001; 3: 211–220.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden

    G Avetisyan, M Hassan & P Ljungman

  2. Department of Hematology, Karolinska University Hospital/Huddinge, Stockholm, Sweden

    G Avetisyan, M Hassan & P Ljungman

  3. Institute of Immunology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary

    E Ragnavölgyi

  4. Department of Medical Chemistry, A. Szentgyorgyi University, Szeged, Hungary

    G T Toth

Authors
  1. G Avetisyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Ragnavölgyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G T Toth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Ljungman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Ljungman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avetisyan, G., Ragnavölgyi, E., Toth, G. et al. Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients. Bone Marrow Transplant 36, 411–415 (2005). https://doi.org/10.1038/sj.bmt.1705064

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705064

Keywords

This article is cited by

Search

Advanced search

Quick links